Back to search

Article

Effect of genetically proxied use of PDE5 inhibitors on risk of CHD: A drug target Mendelian Randomization study

2024-10-22

Abstract excerpt

<title>Abstract</title> <p><bold>Background and aim</bold> There have been previous and recent studies generating conflicting findings on effect of phosphodiesterase 5 (PDE5) inhibitors with CHD, Diabetes, breast cancer and prostatic cancer. Since we intended to use naturally occurring variation in genes encoding PDE5 to investigate association between genetically proxied PDE5 inhibitors and them. <bold>Method</b...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
e168a5cc-45d3-51d6-b533-9f25bfb811b2
DOI
10.21203/rs.3.rs-5236402/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Effect of genetically proxied use of PDE5 inhibitors on risk of CHD: A drug target Mendelian Randomization studyDOI 10.21203/rs.3.rs-5236402/v1
Select a neighboring publication to make it the new centre.